Navigation Links
Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy

- Aggregate Benefit over Placebo Larger at One Year than at Six Months -

SAN FRANCISCO and WASHINGTON, June 11, 2007 /PRNewswire-FirstCall/ -- Medivation, Inc. today announced that the benefits of Dimebon over placebo in its double-blind, placebo-controlled Phase 2 study in mild-to- moderate Alzheimer's disease were statistically significant on all five study endpoints at 12 months. Importantly, on every endpoint studied, the benefits of Dimebon over placebo at one year were stable or greater when compared to benefits at six months. Dimebon patients were stabilized over the one year study period, meaning that their level of function was preserved for a full year on all five endpoints. The endpoints spanned all of the most frequently studied aspects of Alzheimer's disease: cognition, overall clinical function, activities of daily living, and behavioral problems. Dimebon was well tolerated throughout the entire one-year treatment period.

On the study's primary endpoint, the ADAS-cog, Dimebon caused an improvement over placebo of 6.9 points at one year (observed case analysis; p<0.0001). On the global function endpoint used in this study, the CIBIC- plus, Dimebon's benefit over placebo was 0.8 points at 12 months (observed case analysis; p=0.006). Global function improved or remained stable in 69 percent of treated Alzheimer's disease patients after one year of Dimebon therapy. The ADAS-cog and the CIBIC-plus are the two endpoints the U.S. Food and Drug Administration has used to approve all currently marketed drugs for mild-to-moderate Alzheimer's disease.

Dimebon produced an aggregate benefit over placebo in this study that was larger at 12 months than at six. After a year of treatment Dimebon's benefit over placebo was greater than six-month levels on the ADAS-cog (6.9 points vs. 4.0 points), the CIBIC-plus (0.8 points vs. 0.6 points), and the ADCS-ADL (5.2 points vs. 2.9 points); however, only th
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
2. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
3. Medivation Announces First U.S. Presentation of Data From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Medivation Announces Presentation of Full Top-Line Data From Dimebon Six-Month Trial at Major International Alzheimers Disease Conference
5. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
6. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
7. ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine
8. EPIX Pharmaceuticals Announces Statistically Significant Results in Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug Candidate
9. Telik Reports Positive Data Demonstrating Synergy in Combination and Highly Statistically Significant Effect of Telcyta as Maintenance Therapy in First-Line Non-Small Cell Lung Cancer
10. Addex Achieves Statistically Significant Outcome in Phase IIa Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease
11. Repros Proellex Shows Statistically Significant Improvement in Primary Endpoint in Phase 2 Trial in the Treatment of Uterine Fibroids
Post Your Comments:
(Date:5/20/2013)... 20, 2013   National Community Pharmacists Association ... RPh, MBA issued the following statement today regarding a ... Part D "preferred pharmacy" drug plans , which ... plan,s lowest advertised co-payments: (Logo:  http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ... and MedPAC , 16 U.S. Senators ...
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- Today at ... Christine Ginocchio discussed Specific ... for rapid identification of microorganisms producing bloodstream infection. ... Chief of the Division of Infectious Disease Diagnostics ... largest not-for-profit, non-sectarian health system. (Photo: ...
(Date:5/20/2013)... -- Hill-Rom Holdings, Inc. (NYSE: HRC ) invites ... 38 th Annual Deutsche Bank Health Care Conference ... 2013, at 1:30 p.m. EDT. (Logo: ... listen to the live discussion via the internet link ... http://www.media-server.com/m/p/f7bj3q84 . A recorded replay of the discussion ...
Breaking Medicine Technology:Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... 2011 Nopras Technologies, Inc., a ... services for organizations in the Pharmaceutical, Biotechnology, Medical ... January 10th, 2011 that it has achieved ... well documented procedures and processes, its proactive response, ...
... 10, 2011 Drawing attention to its TemporalScanner™ Temporal ... "game-time temperature" for national radio broadcasts of NFL games ... The "Exergen Game Time Temperature" promotion is the only ... Night Football and Monday Night Football regular season games, ...
Cached Medicine Technology:Nopras Technologies, Inc. Achieves ISO 9001:2008 Certification 2Exergen TemporalScanner Sponsors 'Game Time Temperature' for NFL and College Bowl Games 2
(Date:5/20/2013)... 20, 2013 When a shopper decides to ... part of the process. Much of the stress and concern ... not knowing what to expect. Best Mattress Online, a ... use to ensure their purchase proves smooth. , In the ... Mattress Online ”, readers find helpful tips divided into two ...
(Date:5/20/2013)... Fastcare Miami Beach clinic advises patients to ... symptoms, as if not treated, it may involve the ureter ... a urinary tract infection in itself is not life threatening, ... called pyelonephritis. Women seem to have many more urinary tract ... percentage as women after the age of fifty. , ...
(Date:5/20/2013)... Los Angeles, CA (PRWEB) May 20, 2013 ... has just been released to the public creating ... to gain access to this elite business training. ... the course as well as an exclusive bonus. ... known for providing elite business training to individuals ...
(Date:5/20/2013)... 20, 2013 Leading facial plastic surgeon and ... as a “Top Doc” in the field of Otolaryngology in ... , The Palm Beacher magazine, one of Palm Beach County’s ... in the May/June 2013 issue, including 70 of the very ... dining, events, things to do, health and fitness, people to ...
(Date:5/20/2013)... The Environmental Design Research ... of continuing education credit opportunities for design professionals, ... Architects Continuing Education System (AIA/CES), the Landscape Architecture ... Design Continuing Education Council (IDCEC). EDRA44Providence ... at the Omni Providence Hotel in Providence, Rhode ...
Breaking Medicine News(10 mins):Health News:See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online 2Health News:Fastcare Advises on How to Prevent a UTI 2Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2Health News:Environmental Design Research Conference to Feature AIA/CES, LA CES, and IDCEC Continuing Education Credits 2
... Consortium, a group of researchers, clinicians and families dedicated ... autism, announced today that it has completed the first ... Autism Gene Discovery Project and has released the reference ... the world can use. The scan was conducted ...
... (Chicago, IL, October 22, 2007) Hospitalized patients who ... the use of hypnotherapy than patients using other smoking ... the 73rd annual international scientific assembly of the American ... who participated in one hypnotherapy session were more likely ...
... Bayer Consumer Care announces,the availability of the ... Sinus), combining a long-lasting nasal decongestant with the,pain-relieving ... from,multiple sinus and pain symptoms. The combination ... in a recent survey of adults who suffer ...
... upon its impressive past,successes, the Midwest Orthopaedic Research ... will propel it forward in the coming decade. ... product,innovation, will solidify MORF as a world-class research ... MORF will be restructuring the board of directors,and ...
... Mind,s emotion centers less controlled when weary, MRI study shows ... little testy after a bad night,s sleep? Scientists may ... lack of sleep causes the brain,s emotional centers to dramatically ... lobe -- a brain region that normally keeps emotions under ...
... annual awards recognize technology innovation for healthcare., ... Healthcare Users Group (MS-HUG) and Microsoft Corp. today,announced ... Healthcare Innovation,Awards. The contest, open to any healthcare ... improve the quality and delivery of,healthcare. (Logo: ...
Cached Medicine News:Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 2Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 3Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 4Health News:Hypnosis for smoking cessation sees strong results 2Health News:ALEVE-D(R) Sinus & Cold Offers Option for the More Than 50% of Consumers Not Satisfied with Current Sinus Medication 2Health News:ALEVE-D(R) Sinus & Cold Offers Option for the More Than 50% of Consumers Not Satisfied with Current Sinus Medication 3Health News:Sleepless Nights Make for Grumpier Brains 2Health News:Call for Entries Announced for 2008 MS-HUG Innovation Awards 2Health News:Call for Entries Announced for 2008 MS-HUG Innovation Awards 3
... Ergonomic Design for Unparalleled Comfort Pick ... Notice the balance. Notice the trigger and ejector ... Thats because our pipettors are ergonomically designed to ... hours of pipetting. Productivity In The Palm ...
... Ergonomic Design for Unparalleled Comfort ... it. Notice the balance. Notice the trigger and ... left-handed. Thats because our pipettors are ergonomically designed ... long hours of pipetting. Productivity In The ...
... The Finnpipette BioControl multichannel ... features as the single ... handle fits all seven ... channel tip cone modules. ...
... , The new Finnpipette Novus is so user-friendly that ... few minutes. With the intuitive instantly familiar menu and ... functions you need quickly and easily. The large, clear ... names of all functions. The easily accessible two ...
Medicine Products: